Related Experiment Videos
[Acute phase proteins in acute pancreatitis]
F Dujmović1, M Kulauzov, B Danicić
1Zavod za patolosku fiziologiju, Medicinski fakultet, Novi Sad.
Medicinski Pregled
|December 24, 1998
Summary
C-reactive protein (CRP) is a valuable early indicator for severe acute pancreatitis. Elevated CRP and alpha-1-antitrypsin levels at the onset predict a more serious disease course, aiding timely treatment decisions.
Area of Science:
- Biochemistry
- Clinical Medicine
- Immunology
Context:
- Acute pancreatitis affects 10-20% of patients severely.
- Acute phase proteins are increasingly recognized for their role in acute pancreatitis pathophysiology.
- Early identification of severe acute pancreatitis is crucial for timely intervention.
Purpose:
- To evaluate the utility of C-reactive protein (CRP), alpha-1-antitrypsin, and orosomucoid in assessing acute pancreatitis severity.
- To determine if these acute phase proteins can serve as early markers for severe disease.
Summary:
- A study of 150 adult patients with acute pancreatitis (50 severe, 100 mild) measured CRP, alpha-1-antitrypsin, and orosomucoid levels on days 1, 2, 3, 7, and 14.
- Significantly higher CRP levels were observed in severe pancreatitis patients compared to mild cases.
- Elevated alpha-1-antitrypsin also indicated severity, while orosomucoid showed no significant difference between groups and appeared later in the disease course.
Impact:
- CRP emerges as a reliable early marker for predicting severe acute pancreatitis.
- Elevated CRP and alpha-1-antitrypsin at disease onset suggest a future severe course.
- This finding supports the potential for simple, early prognostic assessment using acute phase proteins, unlike traditional scoring systems requiring 48 hours.